J. Caminis

发表

Calcaneal Ultrasonometry: Response to Treatment in Comparison with Dual X-ray Absorptiometry Measurements of the Lumbar Spine and Femur

L. Rosenthall, J. Caminis, A. Tenehouse, 1999, Calcified Tissue International.

A correlative study of ultrasound calcaneal and dual-energy X-ray absorptiometry bone measurements of the lumbar spine and femur in 1000 women

A. Tenenhouse, L. Rosenthall, J. Caminis, 1995, European Journal of Nuclear Medicine.

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double‐Blind, Phase 2, Parallel Group Study

Jacques P. Brown, A. Díez-Pérez, A. Grauer, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Association of a Polymorphism in the TNFR2 Gene with Low Bone Mineral Density

A. Tenenhouse, J. Caminis, H. Tenenhouse, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Jean-Pierre Devogelaer, Patrick Emonts, René Rizzoli, 2016, Aging Clinical and Experimental Research.

Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture.

C. Pieper, J. Caminis, R. Heaney, 2007, The American journal of geriatric pharmacotherapy.

Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects

N. Goel, R. Reeve, J. Caminis, 2018, Pharmacology research & perspectives.

Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials

K. Iyer, D. Seidner, S. Schneider, 2020, Therapeutic advances in gastroenterology.

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

M. Mouksassi, J. Marier, J. Caminis, 2008, Journal of clinical pharmacology.

Vitamin D Receptor Genotype is Not Associated with Bone Mineral Density in Three Ethnic/Regional Groups

A. Tenenhouse, D. Prockop, K. Shimoya, 1996, Calcified Tissue International.

Treatment with Zoledronic Acid Ameliorates Negative Geometric Changes in the Proximal Femur following Acute Spinal Cord Injury

K. Brintzenhofeszoc, T. Beck, J. Caminis, 2007, Calcified Tissue International.

Correlation of ultrasound velocity in the tibial cortex, calcaneal ultrasonography, and bone mineral densitometry of the spine and femur

A. Tenenhouse, L. Rosenthall, J. Caminis, 1996, Calcified Tissue International.

Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute Bleeding Events

C. Négrier, S. Pipe, M. Ragni, 2019, Blood.

A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

M. Bhandari, A. Grauer, T. Miclau, 2020, The Journal of bone and joint surgery. American volume.

Osteopenia in 37 Members of Seven Families: Analysis Based on a Model of Dominant Inheritance

J. Ott, M. Devoto, D. Prockop, 1996, Molecular medicine.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

S. Cummings, S. Boonen, J. Cauley, 2007, The New England journal of medicine.

Bone circuitry and interorgan skeletal crosstalk

T. Yuen, M. Zaidi, Tal Frolinger, 2023, eLife.

Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36.

M. Devoto, C. Specchia, A. Tenenhouse, 2001, Human molecular genetics.

First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q

J. Ott, M. Devoto, L. Ala‐Kokko, 1998, European Journal of Human Genetics.

Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis.

M. Robinson, J. Caminis, M. Brunkow, 2013, Drug discovery today.

Disorders Associated With Acute Rapid and Severe Bone Loss

M. Zaidi, S. Epstein, A. Inzerillo, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture: A Randomized Phase-2 Study.

M. Bhandari, T. Miclau, E. Schemitsch, 2020, The Journal of bone and joint surgery. American volume.

Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial.

A. Thurman, E. Hook, J. Caminis, 2012, Clinical Infectious Diseases.

Safety and Ef fi cacy of WC 2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia trachomatis Infection : A Randomized , Double-blind , Double-Dummy , Active-Controlled , Multicenter Trial

A. Thurman, E. Hook, J. Caminis, 2012 .

The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair

Theodore T. Suh, C. Pieper, J. Magaziner, 2004, Current Medical Research and Opinion.

Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States

M. Hiligsmann, A. Singer, J. Caminis, 2023, PharmacoEconomics.

Development and Biophysical Characterization of a Humanized FSH–Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra–High Concentration

T. Yuen, M. Meseck, M. Zaidi, 2023, bioRxiv.